Bayer, EDB to fund S$30m regional disease research
Effort will deepen cancer research and expand into heart and eye diseases
Singapore
PHARMACEUTICAL giant Bayer HealthCare and the Singapore Economic Development Board (EDB) will jointly foster translational and clinical research for diseases prevalent in Asia over the next five years, they announced at a launch ceremony on Wednesday.
EDB will facilitate collaborations between Bayer HealthCare and its partner institutes - including SingHealth Duke-NUS Academic Medical Centre and National University Health System (NUHS) - to increase existing research efforts in cancer treatment, and expand into the research of heart and eye diseases.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Abu Dhabi’s IHC to buy back up to US$1.4 billion of its shares
Israel strikes Gaza city of Rafah after evacuation order
Britain's King Charles III marks first anniversary of coronation
German deficit forecast at 1.75% in 2024, says stability council
SNP veteran John Swinney set to be Scotland’s next leader
Shell in talks to sell Malaysia fuel stations to Saudi Aramco: sources